Found: 11 articles

Article Edition
Ponezheva Zh.B., Makashova V.V.
Treatment with the first Russian direct-acting antiviral drug in patients with chronic hepatitis C
№4 / 2019
Batskikh S.N., Karandashova I.V., Chula­nov V.P.
Current opportunities and prospects for retreatment in patients with chronic hepatitis C
№5 / 2017
Asratyan A.A., Solov’ev D.V., Smirnova O.A., Kazaryan S.M., Rusakova E.V.
Parenteral viral hepatitides and tuberculosis: Current problems of epidemiology and prevention
№3 / 2017
Salman E.R., Asatryan M.N., Gaidarenko A.D., Ershov I.F., Semenenko T.A.
Predictive assessment of preventable mortality associated with chronic hepatitis C
№6 / 2016
Ignatova T.M.
Use of telaprevir in real clinical practice
№3 / 2014
Ivanova M.R., Marzhokhova M.Yu.
Analysis of the efficiency of antiviral therapy for chronic hepatitis C
№4 / 2013
Kravchenko A.V., Kanestri V.G.
The hepatitis C virus protease inhibitor telaprevir in therapy regimens for chronic hepatitis C in patients with HIV infection
№2 / 2013
Mukomolov S.L., Levakova I.A., Sulyagina L.G., Sinaiskaya E.V., Bolsun D.D., Ivanova N.V.
Current epidemiology of hepatitis C in Russia
№6 / 2012
Sapronov G.V., Belyaeva N.M.
Possibilities of correcting interferon-induced leukopenia in patients with chronic hepatitis C
№4 / 2012
Rogozina N.V., Goryacheva L.G., Shilova I.V., Lutsky A.A., Zheleznikova G.F., Lapin S.V.
The course of chronic hepatitis C and the prevalence of extrahepatic manifestations in children
№5 / 2012
Myazin R.G.
Use of allokin-alpha to stimulate leucopoiesis in patients with chronic viral hepatitis B and C
№3 / 2012


Бионика Медиа